Brief Report - (2016) Volume 5, Issue 1
A Study Design: Concurrent EGFR-TKI and Thoracic Radiotherapy as Firstline
Treatment of Stage IV NSCLC Patients with EGFR Active Mutations
(CERTAIN Study)
- Yan-Mei Wang1, Yu-Zhong Duan1, Rong-Xia Liao2, Yan Li1, Xu Chen1 and Jian-Guo Sun1*
- 1Department of Oncology, Xinqiao Hospital, Third Military Medical University, Chongqing, China
- 2Medical English Department, College of Basic Medicine, Third Military Medical University, Chongqing, China
*Corresponding Author:
Jian-Guo Sun, Department of Oncology, Xinqiao Hospital, Third Military Medical University, Chongqing, China, Tel: +86-23-68774490
Email:
